Disruption of macrophage pro‐inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients. Issue 1 (January 2015)

• Record Type: Journal Article
• Authors: Smith, Andrew M.; Sewell, Gavin W.; Levine, Adam P.; Chew, Thean S.; Dunne, Jenny; O'Shea, Nuala R.; Smith, Philip J.; Harrison, Penelope J.; Macdonald, Carol M.; Bloom, Stuart L.; Segal, Anthony W.
• Is Part Of: Immunology. Volume 144:Issue 1(2015:Jan.)
• Page Start: 45
• Page End: 55
• Publication Date: 2015-01
• Subjects: Immunology -- Periodicals
• DOI: 10.1111/imm.12338
• Languages: English
• ISSNs: 0019-2805

Abstract

<abstract abstract-type="main" id="imm12338-abs-0001"> <title>Summary</title> <p>Crohn's disease (CD) is a complex and highly heterogeneous chronic inflammatory disorder, primarily affecting the gastrointestinal tract. Genetic and functional studies have highlighted a key role for innate immunity in its pathogenesis. Profound systemic defects in innate immunity and acute inflammation are understood to result in markedly delayed clearance of bacteria from the tissues, leading to local chronic granulomatous inflammation and compensatory adaptive immunological changes. Macrophages, key orchestrators of acute inflammation, are likely to play an important role in the initial impaired innate immune response. Monocyte‐derived macrophages from CD patients stimulated with <italic>Escherichia coli</italic> were shown to release attenuated levels of tumour necrosis factor and interferon‐<italic>γ</italic> with normal secretion of interleukin‐8 (IL‐8), IL‐10 and IL‐6. In controls, the secretion of these cytokines was strongly positively correlated, which was not seen with CD macrophages. The transcriptomes of CD and control macrophages were examined in an attempt to understand the molecular basis of this defect. There were no differentially expressed genes identified between the two groups, consistent with genetic heterogeneity; however, a number of molecules were found to be under‐expressed in subgroups of CD patients. The most common of these was optineurin (OPTN) which was under‐expressed in approximately 10% of the CD patients. Reduced OPTN expression coincided with lower intracellular protein levels and diminished cytokine secretion after bacterial stimulation both in the patients and with small interfering RNA knockdown in THP‐1 cells. Identifying and studying subgroups of patients with shared defective gene expression could aid our understanding of the mechanisms underlying highly heterogeneous diseases such as CD.</p> </abstract>